LENZ Therapeutics Statistics

Total Valuation

LENZ has a market cap or net worth of $788.60 million. The enterprise value is $587.32 million.

Market Cap	788.60M
Enterprise Value	587.32M

Important Dates

The next confirmed earnings date is Wednesday, November 6, 2024, before market open.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

LENZ has 27.50 million shares outstanding. The number of shares has increased by 72.32% in one year.

Current Share Class	27.50M
Shares Outstanding	27.50M
Shares Change (YoY)	+72.32%
Shares Change (QoQ)	+442.83%
Owned by Insiders (%)	2.79%
Owned by Institutions (%)	41.89%
Float	12.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.81
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 23.23, with a Debt / Equity ratio of 0.01.

Current Ratio	23.23
Quick Ratio	22.85
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-179,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +79.36% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+79.36%
50-Day Moving Average	24.27
200-Day Moving Average	20.97
Relative Strength Index (RSI)	62.20
Average Volume (20 Days)	144,052

Short Selling Information

The latest short interest is 2.01 million, so 7.31% of the outstanding shares have been sold short.

Short Interest	2.01M
Short Previous Month	1.95M
Short % of Shares Out	7.31%
Short % of Float	16.06%
Short Ratio (days to cover)	17.72

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-75.29M
Pretax Income	-117.37M
Net Income	-69.47M
EBITDA	-75.26M
EBIT	-75.29M
Earnings Per Share (EPS)	-$4.26

Full Income Statement

Balance Sheet

The company has $196.11 million in cash and $1.70 million in debt, giving a net cash position of $194.41 million or $7.07 per share.

Cash & Cash Equivalents	196.11M
Total Debt	1.70M
Net Cash	194.41M
Net Cash Per Share	$7.07
Equity (Book Value)	192.92M
Book Value Per Share	7.46
Working Capital	190.77M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$73.79 million and capital expenditures -$133,000, giving a free cash flow of -$73.92 million.

Operating Cash Flow	-73.79M
Capital Expenditures	-133,000
Free Cash Flow	-73.92M
FCF Per Share	-$2.69

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LENZ does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-72.32%
Shareholder Yield	-72.32%
Earnings Yield	-8.89%
FCF Yield	-9.46%

Dividend Details

Analyst Forecast

The average price target for LENZ is $35.40, which is 23.43% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$35.40
Price Target Difference	23.43%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1